In the face of the COVID-19 pandemic, IQ members remained laser focused on bringing the best science and research to bear in the development and manufacturing of lifesaving drug products. IQ never missed a beat! During 2020, more than 2200 individual participants engaged in IQ initiatives — either through the consortium’s 10 leadership groups or through one or more of the 100+ IQ working groups. IQ’s membership continues to flourish and have great impact on the industry and the patient communities we serve.
We invite you to read our Annual Report 2020 to learn more.